В проучване WV16240 са набирани пациенти, положителни за HBeAg, а в изпитване WV16241 – пациенти, отрицателни за HBeAg и положителни за анти- НВе.
Study WV16240 recruited patients who were positive for HBeAg, while study WV16241 recruited patients who were negative for HBeAg and positive for anti-HBe.